Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 3Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Colorectal Neoplasms 20Rectal Neoplasms 12Colonic Neoplasms 11Head and Neck Neoplasms 6Neoplasm Metastasis 5Carcinoma, Hepatocellular 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Neoplasms 3Keratosis, Actinic 3Esophageal Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Skin Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Nasopharyngeal Neoplasms 2Cholangiocarcinoma 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Tongue Neoplasms 1Recurrence 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Motor Activity 1Melanoma 1Malignant Tumor of Pancreas Metastatic to Liver 1Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 6avelumab 4Magnetic Resonance Spectroscopy 2Docetaxel 2Cisplatin 2ALT-803 2yeast-CEA vaccine 1vadimezan 1trebananib 1obinutuzumab 1naptumomab estafenatox 1erdafitinib 1enfortumab vedotin 1bicalutamide 1atezolizumab 1Ultrasonography 1Specimen Handling 1Ramucirumab 1Radiosurgery 1Phantoms, Imaging 1PM 01183 1Omacor 1Nivolumab 1Neoadjuvant Therapy 1Mitomycin 1Lycopene 1Leucovorin 1High-Intensity Focused Ultrasound Ablation 1Gemcitabine 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Transitional Cell × Fluorouracil × Clear all
NCT03197571 2025-02-21

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

ImmunityBio, Inc.

Phase 1/2 Withdrawn
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡